MyAverix Finance MyAverix Finance

KQ · Healthcare

IBKS No2 SPAC (204840)

Drug Manufacturers - Specialty & Generic

IBKS No2 SPAC (204840) is listed on KQ in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-24

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 204840

P/E ratio
18.00

IBKS No2 SPAC (204840) — FAQ

What is 204840's P/E ratio?

The price-to-earnings (P/E) ratio for IBKS No2 SPAC (204840) is 18.00 (data as of 2026-05-24).

Does IBKS No2 SPAC pay a dividend?

Dividend yield is not available in the current snapshot for IBKS No2 SPAC (204840). Check the MyAverix Finance app for the latest dividend data.

What sector is IBKS No2 SPAC in?

IBKS No2 SPAC (204840) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 204840 listed on?

204840 is listed on KQ.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play